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Abstract
Purpose of Review We seek to describe the relationship be-
tween diabetes mellitus and cardiovascular risk in migrant
South Asians compared to native white Europeans, and to
determine the temporal change in this relationship over recent
years.
Recent Findings Recent evidence suggests that the excess
mortality risk associated with diabetes is lower in the migrant
South Asian population compared with white Europeans. By
contrast, South Asians continue to demonstrate elevated car-
diovascular morbidity compared to white Europeans, al-
though to a lesser extent than was observed in previous
decades.
Summary The excess mortality previously observed in
South Asian migrants has attenuated with a lower mor-
tality risk compared to white Europeans observed in
several recent studies. We speculate that these findings
may relate in part to earlier diabetes diagnosis and more
prolonged exposure to cardiovascular risk factor management
in the South Asian population. Further study is required to
confirm these hypotheses.
Keywords Diabetesmellitus . Type 2 diabetesmellitus .
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Introduction
Diabetes mellitus confers an approximately two-fold increased
risk of cardiovascular morbidity and mortality relative to non-
diabetes [1]. South Asians, particularly South Asian migrants to
high-income countries, have a significantly increased risk of
type 2 diabetes compared with white Europeans. Population
level data from the end of the twentieth century suggested that
South Asian migrants with diabetes mellitus were at increased
risk of complications, both cardiovascular disease (CVD) and
cardiovascular death, relative to their white European counter-
parts [2–4]. However, some recent evidence suggests there is
now less marked disparity in some cardiovascular complica-
tions between these populations, with additional surprising ev-
idence of a lower mortality risk compared to white Europeans
[5]. Our aim is to review the literature in this field and examine
evidence for a temporal change in these relationships. We will
also speculate on the mechanisms behind such changes.
Diabetes Mellitus in Migrant South Asians
There are several million migrant South Asians, including
Indian, Pakistani, Bangladeshi and Sri Lankan individuals,
living outside the Indian subcontinent. The estimated popula-
tion size includes 3 million people in the UK, 3 million people
in the USA and 1.6 million people in Canada [6••]. The prev-
alence of type 2 diabetes mellitus is higher in these popula-
tions compared to the native white populations in the countries
to which they move [2, 7–9]. In the UK, this pattern was first
formally described in the 1985 Southall Diabetes Survey [2].
This community survey of over 65,000 participants in west
London showed a 5-fold higher prevalence of diabetes
mellitus in South Asian residents aged 30 to 64 compared to
their white European neighbours. Modern estimates are more
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modest but show the risk remains elevated by approximately 2
to 4-fold in migrant South Asians compared to white
Europeans [7, 8]. The magnitude of this risk is variable within
the South Asian population with the highest risk seen in the
Bangladeshi community (approximately 4-fold) compared to
a roughly 2-fold risk in the Indian community [8, 9]. The
reasons behind this intra-ethnic heterogeneity in risk are un-
known but require further study.
Aetiology of Diabetes and Cardiovascular Risk
in South Asians
The onset of type 2 diabetes typically occurs 5 to 10 years
earlier in South Asians and the risk begins to increase at far
lower levels of BMI compared with white Europeans [7, 10].
The increased risk of diabetes is likely to relate to multiple
intrinsic and environmental factors. Several potential mecha-
nisms were recently reviewed in detail by Sattar and Gill and
these are summarised in Table 1 [6••].
Cardiovascular Morbidity
The impact of South Asian ethnicity on risk of diabetes-
related complications has been examined in several
population-based studies. However, the nature of the relation-
ship remains uncertain. The 11-year follow-up of the Southall
Diabetes Study, performed in 1995, showed that amongst the
590 surviving diabetic patients, the rate of previous myocar-
dial infarction was almost four times higher in South Asians
compared with white Europeans [11]. However, there was no
significant difference observed in the risk of hypertension,
stroke or amputation. The SABRE cohort presented 20-year
follow-up data from patients initially recruited to the Southall
study between 1988 and 1991 [3]. The risk of stroke was
almost twice as high in South Asians with diabetes compared
with their white European counterparts and the risk of coro-
nary heart disease was also elevated to a lesser extent
(subhazard ratio 1.55; 95% CI 1.38–1.75). The UK Asian
Diabetes Study collected data between 2004 and 2007 from
1486 patients diagnosed with diabetes in the mid-1990s. This
study showed a trend towards increased risk for cardiovascu-
lar events or death from CVD in South Asians compared with
white Europeans; however, this was not statistically signifi-
cant (adjusted odds ratio [OR] 1.4; 95% CI 0.9 to 2.2) [12]. A
large Canadian population-based study of newly diagnosed
diabetic individuals from 2002 to 2009 included almost half
a million participants, 22,432 of whom were South Asian [5].
Over a 5-year follow-up period, the risk of hospitalisation for
coronary artery disease, stroke or lower-extremity amputation
was determined to be broadly similar for South Asian and
white European participants (hazard ratio [HR] 0.95; 95%
CI 0.9–1.00). The UK National Diabetes Audit 2010–11 in-
cluded data from over 2 million patients representing 87.6%
of persons with diabetes in England and Wales [13]. The risk
of several cardiovascular outcomes was elevated in South
Asians compared to white Europeans: myocardial infarction
(OR 1.6; 95%CI 1.5–1.7), angina (OR 1.2; 95%CI 1.18–1.3),
heart failure (OR 1.3; 95% CI 1.2–1.34) and stroke (OR 1.08;
95% CI 1.01–1.2). A Canadian population-based study exam-
ined incidence of macrovascular complications in over
250,000 newly diagnosed persons with diabetes from 1997
to 2007 [14]. In this cohort, South Asian and white European
women had a similar risk of stroke, myocardial infarction and
heart failure. For South Asian men, the risks of heart failure
(HR 0.71; 95% CI 0.56–0.92) and stroke (HR 0.82; 95% CI
0.68–0.99) were lower compared to white European men,
whilst the risk of myocardial infarction was similar. However,
this study did not adjust for important confounders such as
smoking and BMI; therefore, some caution is needed in the
interpretation of the apparent reduced risk of these outcomes.
Nevertheless, taken together these studies broadly support
somewhat higher risks of cardiovascular complications in
South Asians with diabetes relative to their European counter-
parts but risk differences being appreciably lower than seen a
few decades ago. There is however some heterogeneity of risk
levels both between studies and by the nature of the outcomes
examined. Some of these differences may arise from differen-
tial adjustment for confounders and thus further contemporary
and well-designed studies are required in this area. Such stud-
ies conducted in high-income countries would be usefully
complemented by studies in low and middle-income coun-
tries, although one accepts the technical challenges in the ro-
bust capture of data and outcomes in less affluent countries.
Cardiovascular Mortality
As with CVD risk in general, South Asian ethnicity has been
shown to impact the relationship between type 2 diabetes and
mortality, although the nature of this impact is somewhat un-
certain and appears to have meaningfully changed. An in-
creased risk of mortality from CVD in South Asians with type
2 diabetes was demonstrated in national mortality data from
England and Wales collected from 1985 to 1986 [4].
Compared to the native white European population, South
Asians demonstrated increased mortality across the spectrum
of cardiovascular death. Rates of all-cause mortality, cardio-
vascular mortality and stroke deathswere approximately twice
that of Europeans and deaths from ischaemic heart disease
almost three times greater. Relative age-specific mortality
rates showed the ethnic difference to be greatest in the youn-
gest age group, for example ischaemic heart disease death
rates were four times higher in younger South Asians (45 to
64 years), compared with three times higher in those aged 65
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and above. In the Southall 11-year follow-up cohort, collected
in 1995, mortality relating to heart disease and circulatory
deaths in patients aged 30 to 64 at baseline was approximately
twice as high in South Asians compared to white Europeans
[11]. For patients aged 65 and older from the outset of the
study, mortality rates were similar.
By contrast, more recent studies suggest lower mortality
risks in the South Asian diabetic population compared to their
white European counterparts. In the previously mentioned
study by Shah et al., involving incident cases of diabetes in
Canada between 2002 and 2009, the all-cause mortality was
more than 40% lower in South Asians compared to Europeans
(HR 0.56, p < 0.001) over the 5-year follow-up period [5].
Additionally, the Canadian study following newly diagnosed
diabetics over a 10-year follow-up period from 1997 to 2007
showed all-cause mortality was lower in South Asians than
white Europeans (HR 0.69; p < 0.01) [14]. Likewise, the UK
National Diabetes Audit 2010–11 showed all-cause mortality
was almost 50% lower in South Asians compared with white
Europeans (OR 0.53, 95% CI 0.50–0.56) [13]. The 2011–12
National Diabetes Audit provided estimates for type 1 and 2
diabetes and suggested a similarly lower risk of mortality in
South Asians with type 2 (point estimate 0.53; 95% CI 0.5–
0.55) and a more modest difference in risk in South Asians
with type 1 (point estimate 0.75; 0.6–0.9) [15]. Furthermore,
the 2012–2013 National Diabetes Audit showed that the risk
of death from heart failure was in fact lower in South Asians
with both type 2 (−35.2%; 95%CI −37.2 to 33.1%) and type 1
diabetes (−22%, 95% CI −35.2 to −6.1%) compared to white
Europeans [16].
A recent UK population-based study—using the Clinical
Practice Research Datalink (CPRD) cohort—went further and
examined the relationship between ethnicity, life expectancy
and cause-specific mortality for the first time [17••]. A total of
187,968 patients with incident type 2 diabetes between 1998
and 2015 were identified alongside 908,016 non-diabetic con-
trols. The difference in life expectancy between diabetic and
non-diabetic patients was found to be most pronounced within
the white European population and least pronounced in the
South Asian population. For example, in white Europeans at
an attained age of 40 years old, diabetes was associated with a
potential loss of life of 5 years in men and 6 years in women,
findings in keeping with the Emerging Risk Factors publica-
tion a few years before [18]. This is compared to a potential
Table 1 Mechanisms potentially
underlying the higher risk of type
2 diabetes mellitus in South
Asians
Mechanism Evidence
Adiposity At a given BMI, South Asians have a higher fat mass and a larger proportion of fat
in deep abdominal subcutaneous and visceral deposits compared to white
Europeans. There is also some evidence for greater liver fat. Such findings are in
keeping with greater insulin resistance in South Asians
Lean body mass South Asians have less lean tissue than white Europeans for any given BMI. This
relative lack of skeletal muscle and capacity for glucose disposal contributes to
greater insulin resistance and diabetes risk
ß-cell function Compared to white Europeans, South Asians have greater ß-cell function until
adulthood but earlier and more rapid decline in insulin production beyond
middle age. Such evidence requires verification using robust measures of
beta-cell function
Fitness and skeletal
muscle function
South Asians obtain a lower level of cardiorespiratory fitness than white
Europeans for the same level of physical activity and have evidence of reduced
fat oxidation (indicative of impaired muscle metabolism) during submaximal
exercise compared with BMI-matched white Europeans. Once again, studies
using more robust measures of muscle function are required to verify these
findings
Lifestyle South Asians are less physically active than white Europeans. There is no
consistent evidence linking South Asian dietary patterns to increased diabetes
risk; however, short term overfeeding may have greater adverse effects in South
Asians
Genetic factors There is some evidence that epigenetic signals may contribute to the increased risk
of diabetes in South Asians. These signals appear to relate mostly to impaired
beta-cell function. Genetic risk factors for diabetes do not appear to significantly
differ between South Asians and white Europeans
Foetal programming There is little robust evidence for foetal programming underlying the excess risk of
diabetes in South Asians; observational data suggests that increased maternal
fasting blood glucose levels mediate the relationship between South Asian
ethnicity and greater fat mass in offspring but the long-term implications of
this finding is not clear
(Adapted from: Sattar N, Gill JMR. Lancet Diabetes Endocrinol. 2015;3(12):1004–16, with permission from
Elsevier) [6••]
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loss of life of 3 years in South Asian men and less than 2 years
in women. The difference in life expectancy comparing dia-
betic and non-diabetic individuals appeared greatest for both
ethnicities aged 40 and declined with advancing age, in line
with previous evidence that younger onset diabetes is poten-
tially more harmful. Remarkably, however, diabetes was asso-
ciated with a better life expectancy versus non-diabetic counter-
parts in older South Asians (greater than 60 years in women and
65 years in men). Mortality in diabetic South Asians was also
generally lower relative to Europeans for a range of outcomes
including all-causes (HR 0.70, 95% CI 0.65–0.76), CVD (HR
0.82, 95% CI 0.75–216 0.89) cancer (HR 0.43; 95% CI 0.36–
0.51) and respiratory diseases (HR 0.6; 95% CI 0.48–0.76).
The totality of data therefore suggests a beneficial shift in the
pattern of cardiovascular mortality in South Asians with type 2
diabetes. Indeed, the previously observed excess cardiovascular
and all-cause mortality observed in South Asians appears to
have been reversed (Fig. 1).
Speculating on the Mechanisms Underlying Changes
in Mortality Risks
So, what may be the mechanisms underlying such dramatic
changes in mortality risk in migrant South Asians with diabe-
tes? We suggest several factors may operate to explain these
changes, as summarised in Fig. 2.We accept many of these are
speculative and require direct confirmation but we believe our
suggestions are potentially credible.
Over the past 20 years, patients with diabetes have
benefited from the effective cardiovascular risk factor
management with widespread provision of lipid-lowering
and antihypertensive therapies. South Asians typically de-
velop diabetes 5 to 10 years earlier than white Europeans
and are therefore likely to benefit from earlier and more
prolonged exposure to these agents, for example statins and
ACE inhibitors. Although there is no firm evidence that statins
offer a greater lipid-lowering effect to South Asians than white
Europeans, this population does possess a more atherogenic
lipid profile and therefore may accrue greater absolute benefit
from long-term lipid-lowering therapy [19]. Interestingly, Khan
et al. found that the lower mortality observed in South Asians
compared to white Europeans persisted after adjustment for
statin and ACE inhibitor prescribing, although such medica-
tions were only captured at one time point [14]. Other potential
mechanisms could therefore operate, including earlier diagno-
sis of diabetes so that the time between true onset and doctor
diagnosis may have been substantially reduced in recent years,
perhaps particularly in South Asians. In this respect, earlier
studies which reported high mortality in south Asians with
diabetes will have included many more first generation South
Asian migrants who would have had less stringent health care
and longer periods of undiagnosed diabetes, with some having
developed diabetes before they migrated. Consequently,
South Asians with diabetes would have had much worse
glycaemia control around two to three decades ago likely
allied to poorer management of hypercholesterolemia and
hypertension. Whilst glycaemia levels tend to still be
somewhat worse in South Asians with diabetes relative to
white Europeans, such differences are likely to have mark-
edly reduced over the last few decades [20]. Of course, earlier
pick up of diabetes allied to potentially earlier commencement
of statins and blood pressure medications in South Asians
(due to younger average age of onset), plus improved
glycaemia management in general, predict that CVD risks
(fatal and non-fatal) should have reduced markedly over the
last few decades, as appears the case from the aforementioned
review of the literature (Fig. 1).
Of course, the recent apparent lower, not higher, mortality
in South Asians with diabetes cannot be due only to better
Fig. 1 Relative risk of mortality
in migrant South Asians with
diabetes versus white Europeans
reported in papers spanning the
last 3–4 decades. All relevant
studies discussed in the text [4, 5,
11, 13–16, 17••]. IHD ischaemic
heart disease
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glycaemia and lipid management in this ethnic group. We
speculate lower exposure to smoking is relevant and that
lower levels of obesity in South Asians with diabetes may
also be highly relevant. That South Asians need to put on
less weight to develop diabetes relative to their white coun-
terparts means their lifestyles (calorie excess, activity
levels) leading to obesity, as well as some of the down-
stream consequences linked to obesity (but independent
of insulin resistance) such as hypertension must be less
aberrant compared to their non-diabetic counterparts in
comparison to the pattern seen in whites. In whites, indi-
viduals must put on more weight to develop diabetes and
therefore their lifestyle must have undergone bigger deterio-
rations by the time diabetes develops. If true, such findings
would potentially explain lower mortality from several dis-
eases where obesity (and related lifestyle factors) are relevant
and thus, not only deaths from CVD but also from cancer and
respiratory causes might be lower, as appears to be the case
[17••]. Of course, further verification of the recent CPRD
findings would be welcome but it appears that at least in some
high-income countries, CVD risks and related mortality in
south Asians appear vastly reduced. Of course, we accept that
some biases may exist such as the greater arrival of healthier
migrants into high-income countries in recent years although
the continued higher diabetes rates mean that this cannot be
the only explanation.
Conclusion
Our review of the literature suggests CVD risks in general and
mortality risks more so have been markedly lowered in South
Asians with diabetes in high-income countries and that more
work should be done to confirm or refute our proposed mech-
anisms for this remarkable pattern. Finally, it is notable that
such findings appear in stark contrast to the current patterns of
CVD risk in low andmiddle-income South Asian countries, as
recently reported [21]. Thus, whilst the battle to lower CVD
risks is being won in migrant south Asian communities, it is
only just beginning in many developing regions and there is
much progress still to be made in this area worldwide.
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